20882 ⎘
Medicinal preparations containing peptides Enzyme inhibitors
SERINE PROTEINASE INHIBITORS: SERP-1 AND SERP-1 RCL-DERIVED PEPTIDES EFFECT ON MICROBIOME COMPOSITION AND USES THEREOF
#2PHARMACEUTICAL COMPOSITION FOR AORTIC ANEURYSM PROPHYLAXIS AND PROCESSED FOOD
#3USE OF TNKS INHIBITORS FOR REGENERATION OF CARTILAGE
#4EXPRESSION CASSETTE FOR TARGET GENE AND USE THEREOF
#5PIC1 INHIBITION OF MYELOPEROXIDASE OXIDATIVE ACTIVITY IN AN ANIMAL MODEL
#6THANOTRANSMISSION POLYPEPTIDES AND THEIR USE IN TREATING CANCER
#7CELL-REACTIVE, LONG-ACTING, OR TARGETED COMPSTATIN ANALOGS AND RELATED COMPOSITIONS AND METHODS
#8COMPOSITIONS AND METHODS FOR TREATING EPILEPSY, SEIZURES AND OTHER CONDITIONS
#9MAKING AND USING IN VITRO SYNTHESIZED ssRNA FOR INTRODUCING INTO MAMMALIAN CELLS TO INDUCE A BIOLOGICAL OR BIOCHEMICAL EFFECT
#10EXTRACELLULAR MATRIX SHEET STRUCTURES
#11COMPOSITIONS AND METHODS FOR TREATMENT OF SEPSIS-RELATED DISORDERS
#12COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING TRANSPLANT-ASSOCIATED INJURY
#13LISINOPRIL FORMULATIONS
#14PIC1 INHIBITION OF MYELOPEROXIDASE OXIDATIVE ACTIVITY IN AN ANIMAL MODEL
#15NOVEL THERAPEUTIC COMPRISING A SECRETOME FROM MESENCHYMAL STEM CELLS OF UMBILICORD TISSUE OR WHARTON'S JELLY
#16DESIGN AND DEVELOPMENT OF A NOVEL MESSENGER RNA THERAPEUTIC TO TREAT ATHEROSCLEROSIS
#17COMPOSITIONS AND METHODS FOR TREATING ALLERGIC INFLAMMATORY CONDITIONS
#18MUSCLE REGENERATION
#19METHODS AND COMPOUNDS FOR THE TREATMENT OR PREVENTION OF SEVERE INFLUENZA
#20SUPRAMOLECULAR FILAMENTS BASED VIRAL PARTICLE CAPTURE FOR PREVENTION AND THERAPY OF VIRAL INFECTION
#21SERINE PROTEINASE INHIBITORS: SERP-1 AND SERP-1 RCL-DERIVED PEPTIDES EFFECT ON MICROBIOME COMPOSITION AND USES THEREOF
#22Lisinopril formulations
#23TARGETS AND BIOMARKERS FOR TUMOR MICROENVIRONMENTS
#24Compositions and methods for treating epilepsy, seizures and other conditions
#25COMPOSITIONS FOR TREATING HEART DISEASE BY INHIBITING THE ACTION OF mAKAP-beta
#26CARDIOMYOCYTES AND COMPOSITIONS AND METHODS FOR PRODUCING THE SAME
#27Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the CNS
#28STING LEVELS AS A BIOMARKER FOR CANCER IMMUNOTHERAPY
#29METHOD TO TREAT LIPID DYSREGULATION BY MODULATING ACTIVITY OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) PROTEIN WITH SMALL MOLECULE LIGANDS
#30MEK1 Mutation Conferring Resistance to RAF and MEK Inhibitors
#31METHODS AND COMPOSITIONS FOR INCREASING THE CONCENTRATION OF CELL FREE DNA
#32COMPOSITIONS AND METHODS OF TREATING A PI3K MEDIATED DISEASE
#33ROR2 INHIBITORS AND USE THEREOF IN TREATING AND/OR PREVENTING CARTILAGE LOSS
#34THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE
#35COMPOSITIONS OF CASPASE INHIBITORS AND METHODS OF USE THEREOF
#36Nucleic Acid-Derivatized Therapeutics
#37APPLICATION OF SUBSTANCE THAT REDUCES THE CONTENT OR ACTIVITY OF KAT7 IN PREVENTING SENESCENCE AND TREATING HEPATIC FIBROSIS
#38GAMMA SECRETASE MODULATORS FOR THE TREATMENT OF IMMUNE SYSTEM DYSFUNCTION
#39Lisinopril formulations
#40DETECTION AND TREATMENT OF INTESTINAL FIBROSIS
#41Collagen daily with enzyme inhibitors for anti-aging
#42Compositions and methods for treating epilepsy, seizures and other conditions
#43PIC1 inhibition of myeloperoxidase oxidative activity in an animal model
#44TREATMENT OF VASCULAR EHLERS-DANLOS SYNDROME AND RELATED SYNDROMES
#45Compositions and methods for treatment of sepsis-related disorders
#46COMBINATION PHARMACEUTICAL OF TEMOZOLOMIDE AND MUTANT IDH1 ENZYME INHIBITOR
#47EFFECTIVE TREATMENTS FOR VASCULAR ASSOCIATED MACULOPATHY, SEVERE MACULOPATHY, LATE-STAGE MACULOPATHY, AND ABERRANT CHORIOCAPILLARIS
#48Compositions and methods for treating epilepsy, seizures and other conditions
#49ACETYLCHOLINE MODULATION OF IMMUNE FUNCTION
#50LIPOPROTEIN TARGETING PROTEASE INHIBITORS AND USES
#51MUSCLE REGENERATION
#52Compositions and methods for treating allergic inflammatory conditions
#53Method of Treating COVID-19
#54METHOD OF TREATING OR AMELIORATING CANCERS DRIVEN BY RECEPTOR TYROSINE KINASE FUSION ONCOGENES, AND COMPOSITIONS FOR THE SAME
#55CELL-REACTIVE, LONG-ACTING, OR TARGETED COMPSTATIN ANALOGS AND RELATED COMPOSITIONS AND METHODS
#56ENHANCEMENT OF CD47 BLOCKADE THERAPY BY PROTEASOME INHIBITORS
#57ARYL AND HETEROARYL COMPOUNDS, AND THERAPEUTIC USES THEREOF IN CONDITIONS ASSOCIATED WITH THE ALTERATION OF THE ACTIVITY OF GALACTOCEREBROSIDASE
#58Pharmaceutical composition containing B-lapachone as active ingredient for prevention or treatment of cholestatic liver disease
#59TREATMENT OF LIVER INJURY
#60Compositions targeting the interaction domain between p27KIP1 and Brk and methods of use thereof to inhibit p27 Y phosphorylation and cdk4 activity
#61METHOD FOR NEUTRALIZING STOMACH ACID USING ALGINATE, POLYLYSINE, AND SEED PRESERVATIVES
#62COMPOSITIONS AND METHODS FOR TREATING EPILEPSY, SEIZURES AND OTHER CONDITIONS
#63Compositions and methods for treating epilepsy, seizures and other conditions
#64TREATMENT OF MEDICAL CONDITIONS BY STEM CELL TRANSPLANTS AND STEM CELL ACTIVATION
#65NOVEL THERAPEUTIC USE
#66Method For Treating Cancer With Xenogeneic Tissue Cell Composition Of Similar Or Same Histological Type
#67TYPE V PHOSPHODIESTERASE INHIBITOR COMPOSITIONS, METHODS OF MAKING THEM AND METHODS OF USING THEM IN PREVENTING OR TREATING ELEVATED PULMONARY VASCULAR PRESSURE OR PULMONARY HEMORRHAGES
#68ANTIBACTERIAL COMPOUNDS
#69METHODS AND COMPOSITIONS FOR TREATMENT OF PANCREATIC CANCER
#70NOVEL COMPOUNDS
#71Cardiomyocytes and compositions and methods for producing the same
#72METHODS OF TREATMENT
#73FORMULATIONS USING LITHIUM TO TREAT GOUT ARTHROPATHY
#74TREATMENT OF GENETIC DISEASES CHARACTERIZED BY UNSTABLE mRNAs
#75COMPOSITIONS AND METHODS TO TREAT METASTATIC GASTROINTESTINAL CANCER
#76METHODS AND COMPOSITIONS FOR TREATING CENTRAL NERVOUS SYSTEM COCCIDIOIDOMYCOSIS WITH NIKKOMYCIN Z MICRO DOSING
#77Exosome-based cancer assays
#78SKIN COMPOSITION
#79PHARMACEUTICAL COMPOSITION FOR TREATING INSOMNIA
#80PHARMACEUTICAL COMPOSITION CONTAINING B-LAPACHONE AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CHOLESTATIC LIVER DISEASE
#81THANOTRANSMISSION POLYPEPTIDES AND THEIR USE IN TREATING CANCER
#82COMPOSITION USED FOR COMBATING METABOLIC DISEASES AND USES OF COMPOSITION
#83PHARMACEUTICAL COMPOSITION FOR AORTIC ANEURYSM PROPHYLAXIS AND PROCESSED FOOD
#84DRUG COMBINATION FOR USE IN THE TREATMENT OF INFLAMMATORY DISEASES
#85COMBINATION PRODUCT CONTAINING LIMONOID COMPOUND AND SGLT-2 INHIBITOR
#86METHODS AND COMPOSITIONS FOR INHIBITING GLYOXALASE 1 (GLO1)
#87Composition for treating cancer and use and medicament thereof
#88COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISEASES
#89Use For JNK Inhibitor Molecules For Treatment Of Various Diseases
#90USE OF INHIBITORS OF YAP AND SOX2 FOR THE TREATMENT OF CANCER
#91METHOD FOR TREATING ALZHEIMER'S DISEASE BY REGULATING AMINO ACID LEVEL
#92Methods and compounds for the treatment or prevention of severe influenza
#93MODULATION OF DENDRITIC CELL FUNCTION BY THE PHOSPHOLIPID MESSENGER LPA
#94GPCR HETEROMER INHIBITORS AND USES THEREOF
#95ACETYLCHOLINE MODULATION OF IMMUNE FUNCTION
#96Anti-inflammatory treatment via inhibition of endothelial cell kinesin light chain 1, variant 1 (KLC1C)
#97Making and using in vitro-synthesized ssRNA for introducing into mammalian cells to induce a biological or biochemical effect
#98MODULATORS OF TELOMERE DISEASE
#99Extracellular matrix (ECM) structures for tissue regeneration
#100COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE DISEASES AND CANCERS
#101Lipoprotein targeting protease inhibitors and uses
#102Compositions for treating heart disease by inhibiting the action of mAKAP-β
#103Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity
#104ANTISENSE OLIGOMERS AND USES THEREOF
#105Lisinopril formulations
#106Serine proteinase inhibitors: Serp-1 and Serp-1 RCL-derived peptides effect on microbiome composition and uses thereof
#107USE OF RNAI INHIBITING PARP ACTIVITY FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF CANCER
#108Cancer treatment by blocking host-induced IL-1 in combination with radiotherapy
#109Pharmaceutical composition for preventing or treating obesity or sarcopenia, containing IF1 as active ingredient
#110Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making
#111METHODS OF DIAGNOSING AND TREATING VASCULAR ASSOCIATED MACULOPATHY AND SYMPTOMS THEREOF
#112INHIBITION OF ENDOGENOUS REVERSE TRANSCRIPTASE AND TARGETING OF CELLS FOR PROPHYLAXIS AND THERAPY OF CANCER AND AGING
#113USE OF TNKS INHIBITORS FOR REGENERATION OF CARTILAGE
#114GENOTYPE-DIRECTED LOCAL DELIVERY OF TARGETED THERAPEUTICS
#115Method to treat lipid dysregulation by modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) protein activity with small molecule ligands
#116PIC1 inhibition of myeloperoxidase oxidative activity in an animal model
#117Targeting the renin-angiotensin system for treatment of environment-and pathogen-induced lung injury
#118Reducing systemic regulatory T cell levels or activity for treatment of amyotrophic lateral sclerosis
#119Forms and compositions of a MK2 inhibitor
#120Multimeric IL-15-based molecules
#121MUSCLE REGENERATION
#122Reducing systemic regulatory T cell levels or activity for treatment of amyotrophic lateral sclerosis
#123Lisinopril formulations
#124EFFICACY OF AN ANTI-C5 ANTIBODY IN THE PREVENTION OF ANTIBODY MEDIATED REJECTION IN SENSITIZED RECIPIENTS OF KIDNEY TRANSPLANT
#125Fusions and method for detecting same
#126Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity
#127Methods of identifying risk of vascular endothelial growth factor (VEGF) pathway inhibitor-induced hypertension
#128Bicyclic peptide ligands and uses thereof
#129Emodin for Use in Regulating Expression of Proteins Involved in Inflammation
#130Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods
#131STING levels as a biomarker for cancer immunotherapy
#132Enhancing radiation sensitivity comprising administering PMVK inhibiting siRNA and shRNA
#133Therapeutically active compounds and their methods of use
#134METHODS OF DISRUPTING A BIOFILM AND/OR PREVENTING FORMATION OF SAME
#135MODIFIED OLIGONUCLEOTIDES AND METHODS OF USE
#136BLOCKADE OF TIM-1 PATHWAYS and P-SELECTIN PATHWAYS IN TREATMENT OF NEUROINFLAMMATORY DEGENERATIVE DISEASE
#137COMPOSITIONS AND METHODS FOR TREATING HEART DISEASE AND/OR INJURY
#138MEK1 mutation conferring resistance to RAF and MEK inhibitors
#139MODULATION OF HSD17B13 EXPRESSION
#140Peptide based PCSK9 vaccine
#141Cosmetic compositions and methods of use
#142Pharmaceutical formulations of C1 esterase inhibitor
#143Use of autoinducer-related pathway in inducing apoptosis and anti-infective therapy
#144USE OF TETRASPANIN-2 FOR TREATING DIABETES AND SCREENING AN ANTI-DIABETIC AGENT
#145USE OF INHIBITORS OF IL-36 PROTEOLYTIC PROCESSING FOR THE TREATMENT AND/OR REDUCTION OF INFLAMMATION
#146PROTECTION OF NORMAL TISSUE IN CANCER TREATMENT
#147Molecular Size of Elastin-Like Polypeptide Delivery System for Therapeutics Modulates Deposition in the Placenta
#148Neuroprotective peptide
#149ROR2 inhibitors and use thereof in treating and/or preventing cartilage loss
#150Proteasome inhibitors
#151PI3K gamma inhibitor peptide for treatment of respiratory system diseases
#152Compositions for treating heart disease by inhibiting the action of mAKAPβ
#153IMMUNOGENIC COMPOSITIONS AND USES THEREFOR
#154TREATMENTS AND DIAGNOSTICS FOR CANCERS
#155DIETARY PRODUCT
#156Compositions and methods for treatment of sepsis-related disorders
#157Compositions and methods for the treatment of cancer
#158Therapeutic cationic peptides and unimolecular nanoparticles for efficient delivery thereof
#159Multimeric IL-15-based molecules
#160Method for treating a neurological disorder comprising administering ASM inhibitors
#161Method to treat lipid dysregulation by modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) protein activity with small molecule ligands
#162Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity
#163METHODS OF DIAGNOSING AND TREATING VASCULAR ASSOCIATED MACULOPATHY AND SYMPTOMS THEREOF
#164Lisinopril formulations
#165USE OF RNAI INHIBITING PARP ACTIVITY FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF CANCER
#166PIC1 inhibition of myeloperoxidase oxidative activity in an animal model
#167Methods of treating exacerbated inflammatory response with topoisomerase I inhibitors
#168Methods for treating depression and major depressive disorder
#169JNK Inhibitor Molecules For Treatment Of Various Diseases
#170LISINOPRIL FORMULATIONS
#171COMPOUNDS AND METHODS FOR INHIBITING CDK5 ALLEVIATE CARDIAC PHENOTYPES IN TIMOTHY SYNDROME AND RELATED CONDITIONS
#172Anti-inflammatory treatment via inhibition of endothelial cell kinesin light chain 1, variant 1 (KLC1C)
#173Methods for preventing and treating pneumocystis infections
#174Forms and compositions of a MK2 inhibitor
#175Anti-PACAP antibody
#176Pharmaceutical composition containing ATPIF1 for treatment of diabetes
#177COMPOSITIONS AND METHODS FOR WOUND CLOSURE
#178Use for JNK inhibitor molecules for treatment of various diseases
#179Compositions and methods for treatment of uremic cardiomyopathy
#180LIPOPROTEIN TARGETING PROTEASE INHIBITORS AND USES
#181Methods of treating cancer by administering inhibitory RNA molecules targeting protease serine 2 (PRSS2) expression
#182Compositions and methods for treating retinopathy
#183Agent for inhibiting or reducing light sensitivity
#184Compositions and methods of treating root avulsion injury
#185Methods of Treating Angiogenesis-Related Disorders Using JNK3 Inhibitors
#186TREATMENTS FOR HEART FAILURE AND CARDIAC ISCHAEMIC REPERFUSION INJURY
#187Cancer treatment by blocking host-induced IL-1 in combination with radiotherapy
#188PI3Kγ inhibitor peptide for treatment of respiratory system diseases
#189Methods and compounds for the treatment or prevention of severe influenza
#190Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity
#191METHODS FOR INHIBITING NONALCOHOLIC STEATOHEPATITIS, NONALCOHOLIC FATTY LIVER DISEASE, AND/OR DE NOVO LIPOGENESIS
#192Emodin for Use in Gastrointestinal Cancer Therapy
#193Making and using in vitro-synthesized ssRNA for introducing into mammalian cells to induce a biological or biochemical effect
#194Therapeutically active compounds and their methods of use
#195Compositions targeting the interaction domain between p27Kip1 and Brk and methods of use thereof to inhibit p27 Y phosphorylation and cdk4 activity
#196Method for producing protease degradation composition
#197CONTROLLED-RELEASE APOPTOSIS MODULATING COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS
#198Compositions and methods for treating heart disease and/or injury
#199Methods to enhance microvascular engraftment of bioengineered and primary tissues
#200Enhancement of CD47 blockade therapy by proteasome inhibitors
#201Methods and compositions for managing neuroinflammation and neurodegeneration
#202COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING TRANSPLANT-ASSOCIATED INJURY
#203Combinatory treatment strategies of cancer based on RNA polymerase I inhibition
#204Compositions for preserving photoreceptor cells, retinal pigment epithelial cells, or visual function
#205Modulators of telomere disease
#206PIC1 inhibition of myeloperoxidase oxidative activity in an animal model
#207Lisinopril formulations
#208Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods
#209Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
#210Combination Therapy
#211PHARMACEUTICAL FORMULATIONS OF C1 ESTERASE INHIBITOR
#212Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity
#213GENOTYPE-DIRECTED LOCAL DELIVERY OF TARGETED THERAPEUTICS
#214Salbutamol-containing ophthalmic medicament
#215Muscle regeneration
#216Extracellular matrix sheet structures
#217Methods for treating diabetic neurotherapy
#218METHODS FOR TREATING CONTRACTURED MUSCLE AND RELATED CULTURED CELLS
#219Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
#220Decoy peptides inhibiting protein phosphatase 1-medicated dephosphorylation of phospholamban
#221Treatment of Cerebral Cavernous Malformations
#222Anti-PACAP antibody
#223Methods and compositions for preserving retinal ganglion cells
#224TKI permeability enhancers
#225Immunogenic peptides of SCD1 protein
#226Enhancing plasmin activity to prevent soft tissue calcification
#227Antisense oligomers and uses thereof
#228Composition and Method for Therapeutic Agent Delivery During Pregnancy
#229Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases
#230METHOD FOR IDENTIFYING BIOACTIVE PROTEIN, AND BIOACTIVE PROTEIN OBTAINED BY SAID METHOD
#231Fusions and method for detecting same
#232USE OF MK2 INHIBITOR PEPTIDE-CONTAINING COMPOSITIONS FOR TREATING NON-SMALL CELL LUNG CANCER WITH SAME
#233Methods for preventing and treating pneumocystis infections
#234NOVEL PROTEINS SPECIFIC FOR PYOVERDINE AND PYOCHELIN
#235NOVEL PROTEINS SPECIFIC FOR PYOVERDINE AND PYOCHELIN
#236Methods for treating obesity
#237NOVEL PROTEINS SPECIFIC FOR PYOVERDINE AND PYOCHELIN
#238Lisinopril formulations
#239COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE DISEASES AND CANCERS
#240Bicyclic peptide ligands and uses thereof
#241EFFICACY OF AN ANTI-C5 ANTIBODY IN THE PREVENTION OF ANTIBODY MEDIATED REJECTION IN SENSITIZED RECIPIENTS OF A KIDNEY TRANSPLANT
#242Compositions and methods for the treatment of cancer
#243Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity
#244Compositions for treating heart disease by inhibiting the action of mAKAP-β
#245METHODS OF DIAGNOSING AND TREATING VASCULAR ASSOCIATED MACULOPATHY AND SYMPTOMS THEREOF
#246Use of peptides to stimulate the immune system
#247Identification of cyclic peptide agonists of galanin receptor 2 and 3 guided by spexin solution structure
#248Treatments and diagnostics for cancers
#249Method for treating a degenerative neurological disorders comprising administering ASM inhibitor
#250Leukocyte infiltration promoting agent and antitumor immunostimulatory agent
#251Extracellular Matrix Sheet Structures
#252Therapeutic cationic peptides and unimolecular nanoparticles for efficient delivery thereof
#253Inhibition of MK2 in the treatment of cancer
#254PCSK9 INHIBITORY POLYPOLYPEPTIDES AND METHODS OF USE
#255MULTIMERIC IL-15-BASED MOLECULES
#256Therapeutically active compositions and their methods of use
#257IMMUNE CHECKPOINT CHIMERIC ANTIGEN RECEPTORS THERAPY
#258RKIP AGONISM IN THE TREATMENT AND PREVENTION OF HEART FAILURE
#259Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease
#260METHOD OF TREATING CANCER
#261Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
#262Reducing systemic regulatory T cell levels or activity for treatment of alzheimer's disease
#263Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease
#264Reducing systemic regulatory T cell levels or activity for treatment of alzheimer's disease
#265Compositions and methods of treating neurological disorder and stress-induced conditions
#266Compositions for preventing and/or treating pathological conditions associated with alpha-glucosidase
#267COMPOSITIONS TO DISRUPT PROTEIN KINASE A ANCHORING AND USES THEREOF
#268Proteins specific for pyoverdine and pyochelin
#269PI3K gamma inhibitor peptide for treatment of respiratory system diseases
#270Use of Tetraspanin-2 for Treating Diabetes and Screening an Anti-diabetic agent
#271BRUTON'S TYROSINE KINASE INHIBITOR COMBINATIONS AND USES THEREOF
#272Products and methods using soy peptides to lower total and LDL cholesterol levels
#273APPLICATION OF SYK SERVING AS THERAPEUTIC TARGET FOR HEPATIC FIBROSIS/HEPATIC CIRRHOSIS
#274Peptide having skin whitening activity, and use thereof
#275COMPOSITIONS AND METHODS FOR EFFICACIOUS AND SAFE DELIVERY OF SIRNA USING SPECIFIC CHITOSAN-BASED NANOCOMPLEXES
#276Proteins specific for pyoverdine and pyochelin
#277Proteins specific for pyoverdine and pyochelin
#278Proteins specific for pyoverdine and pyochelin
#279Combinations of proteasome inhibitors and cyclic peptides
#280Use of RNAI Inhibiting PARP Activity for the Manufacture of a Medicament for the Treatment of Cancer
#281Inhibition and diagnostics of emerging tetracycline resistance enzymes
#282STAT3 and ERK signal pathway inhibitor comprising mogrosides and analogs thereof
#283HYBRID PROTEINACEOUS MOLECULE CAPABLE OF INHIBITING AT LEAST ONE ANTIBIOTIC AND PHARMACEUTICAL COMPOSITION CONTAINING IT
#284Selective Nox-1 inhibitor peptides and uses thereof
#285BLOCKADE OF TIM-1 PATHWAYS and P-SELECTIN PATHWAYS IN TREATMENT OF NEUROINFLAMMATORY DEGENERATIVE DISEASE
#286LIPOPROTEIN TARGETING PROTEASE INHIBITORS AND USES
#287Extracellular Matrix Structures
#288Extracellular matrix sheet structures
#289Rho associated kinase (ROCK) inhibitors and their use in treating disease
#290Administration of berberine metabolites
#291Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various diseases
#292COMPOSITIONS AND METHODS FOR LONG ACTING PROTEINS
#293Method for treatment of inflammatory skin disorders with inhibitors of IL-36 proteolytic processing
#294Proteins specific for pyoverdine and pyochelin
#295Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity
#296Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
#297Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making
#298Methods and compositions for preserving photoreceptor and retinal pigment epithelial cells
#299Heparanase inhibitory peptides and use thereof for treating clinical pathologies
#300Use for JNK Inhibitor Molecules for Treatment of Various Diseases